Skip to content

Clinical trials

Neoplasms by Site trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: Switzerland Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20151
20172
20191
20202
20213
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Eli Lilly and Company2
Hoffmann-La Roche2
BeiGene USA, Inc.1
Blueprint Medicines Corporation1
Boston Scientific Corporation1
Bristol-Myers Squibb1
Cogent Biosciences, Inc.1
Novartis Pharmaceuticals1
Steba Biotech S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site14
Neoplasms13
Breast Neoplasms6
Breast Diseases5
Carcinoma4
Carcinoma, Bronchogenic4
Carcinoma, Non-Small-Cell Lung4
Lung Diseases4
Lung Neoplasms4
Neoplasm Metastasis4

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.